Stock A009420 HANALL BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Hanall Biopharma Co., Ltd.

Equities

A009420

KR7009420001

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
30,950 KRW +0.65% Intraday chart for Hanall Biopharma Co., Ltd. -7.20% -30.14%
05-14 Hanall Biopharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-03 HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
HANALL BIOPHARMA CO., LTD.
Other Pharmaceuticals
+0.65%-7.20%-30.14%+49.16%+24.30% 1.14B
Bearish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. A009420 Stock
  4. Charts Hanall Biopharma Co., Ltd.
  5. Comparison Chart